EVAg

SARS-CoV-2 collection

Visit our page dedicated to antiviral compounds test results against SARS-CoV-2

Given the epidemiological situation concerning SARS-CoV-2, a simplified and faster procedure has been put in place for the supply of molecular diagnostics control and viral strains to the scientific community worldwide.

Here is the list of the available products on our website:
Virus Products
REF/SKU Variant
003V-05665 rSCV
008V-05664 SARS-CoV-2, human, 2023, Italy, clade GRA, lineage XBB.1.16, Omicron (XBB.1.16-like), strain hCoV-19/Italy/LAZ-INMI-5327/2023, VOI GRA (XBB.1.16+XBB.1.16.*) first detected in India 21K/Omicron (B.1.1.529)
008V-05662 SARS-CoV-2, human, 2023, Italy, clade GRA, lineage JN.1, Omicron (BA.2-like), strain hCoV-19/Italy/LAZ-INMI-5946/2023, VOI GRA (JN.1+JN.1.*) first detected in Luxembourg/Iceland 21K/Omicron (B.1.1.529)
008V-05661 SARS-CoV-2, human, 2023, Italy, clade GRA, lineage BA.2.86.1, Omicron (BA.2-like), strain hCoV-19/Italy/LAZ-INMI-5965/2023, VOI GRA (BA.2.86+BA.2.86.* excluding JN.1, JN.1.*) first detected in Denmark/Israel/USA
008V-05660 SARS-CoV-2, human, 2023, Italy, clade GRA, lineage EG.5.1, Omicron (XBB.1-like), strain hCoV-19/Italy/LAZ-INMI-5565/2023, VOI GRA (EG.5+EG.5.*) first detected in Indonesia/France
008V-05659 SARS-CoV-2, human 2023, Italy, clade GRA, lineage XBB.1.5.6, Omicron (XBB-like), strain hCoV-19/Italy/LAZ-INMI-4810/2023, VOI GRA (XBB.1.5+XBB.1.5.*) first detected in Austria/India/Bangladesh
008V-05658 SARS-CoV-2, human, 2023, Italy, clade GRA, lineage XBB.1.9.1, Omicron (XBB-like), strain hCoV-19/Italy/LAZ-INMI-4945/2023, VUM GRA (XBB.1.9.1+XBB.1.9.1.*) first detected in Indonesia/Israel/Singapore
008V-05657 SARS-CoV-2, human, 2022, Italy, clade GRA, lineage XBB.1, Omicron (XBB.1-like), strain hCoV-19/Italy/LAZ-INMI-4359/2022, VUM GRA (XBB+XBB.* excluding XBB.1.5, XBB.1.16, XBB.1.9.1, XBB.1.9.2, XBB.2.3) first detected in India
008V-05656 SARS-CoV-2, human, 2022, Italy, clade GRA, lineage BQ.1.1, Omicron (BA.5-like), strain hCoV-19/Italy/LAZ-INMI-4044/2022, former VOC Omicron GRA (B.1.1.529+BA.*) first detected in Botswana/Hong Kong/South Africa 21K/Omicron (B.1.1.529)
008V-05655 SARS-CoV-2, human, 2022, Italy, clade GRA, lineage BQ.1.1, Omicron (BA.5-like), strain hCoV-19/Italy/LAZ-INMI-4063/2022, former VOC Omicron GRA (B.1.1.529+BA.*) first detected in Botswana/Hong Kong/South Africa 21K/Omicron (B.1.1.529)
008V-05654 SARS-CoV-2, human, Italy, clade GRA, lineage BA.5.1, Omicron (BA.5-like), strain hCoV-19/Italy/LAZ-INMI-3329/2022, former VOC Omicron GRA (B.1.1.529+BA.*) first detected in Botswana/Hong Kong/South Africa 21K/Omicron (B.1.1.529)
008V-05653 SARS-CoV-2, human, Italy, clade GRA, lineage BA.4, Omicron (BA.4-like), strain hCoV-19/Italy/LAZ-INMI-3316/2022, former VOC Omicron GRA (B.1.1.529+BA.*) first detected in Botswana/Hong Kong/South Africa 21K/Omicron (B.1.1.529)
001V-05625 SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2023/FR/RKL, GS.1.4 21K/Omicron (B.1.1.529)
008V-05613 SARS-CoV-2, human, 2021, Italy, clade GRA, lineage BA.1.17, Omicron (BA.1-like), strain hCoV-19/Italy/LAZ-INMI-2891/2021, former VOC Omicron GRA (B.1.1.529+BA.*) first detected in Botswana/Hong Kong/South Africa 21K/Omicron (B.1.1.529)
001V-05608 SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2023/FR/SeCO, XBB.1.16 21K/Omicron (B.1.1.529)
008V-05601 SARS-CoV-2, H. sapiens, 2021, Italy, clade GRA, lineage BA.1.14, Omicron (BA.1-like), strain hCoV-19/Italy/LAZ-INMI-2890/2021, former VOC Omicron GRA (B.1.1.529+BA.*) first detected in Botswana/Hong Kong/South Africa 21K/Omicron (B.1.1.529)
008V-05600 SARS-CoV-2, H. sapiens, 2021, Italy, clade GRA, lineage BA.1.1, Omicron (BA.1-like), strain hCoV-19/Italy/LAZ-INMI-2889/2021, former VOC Omicron GRA (B.1.1.529+BA.*) first detected in Botswana/Hong Kong/South Africa 21K/Omicron (B.1.1.529)
008V-05599 SARS-CoV-2, former VOC Delta GK (B.1.617.2+AY.*) first detected in India, strain hCoV-19/Italy/LAZ-INMI-1224isl/2021 (clade GK, lineage AY.1, Delta (B.1.617.2-like) +K417N) 21A/Delta (B.1.617.2)
008V-05598 SARS-CoV-2 virus, former VOC Delta GK (B.1.617.2+AY.*) first detected in India, strain hCoV-19/Italy/LAZ-INMI-648isl/2021 (clade GK, lineage B.1.617.2, Delta (B.1.617.2-like)) 21A/Delta (B.1.617.2)
006V-05597 SARS-CoV-2 strain Slovakia/SK-BMC-KR54/2021- B.1.160 variant 20A.EU2
006V-05596 SARS-CoV-2 strain Slovakia/SK-BMC-KR43/2021- B.1.258 variant 20A.EU2
006V-05595 SARS-CoV-2 strain Slovakia/SK-BMC-BA51/2023- Omicron VOC FY.5 21K/Omicron (B.1.1.529)
006V-05594 SARS-CoV-2 strain Slovakia/SK-BMC-BA49/2023- Omicron VOC XBB.1.5 21K/Omicron (B.1.1.529)
006V-05593 SARS-CoV-2 strain Slovakia/SK-BMC-BA47/2023- Omicron VOC BA.5.2.35 21K/Omicron (B.1.1.529)
006V-05592 SARS-CoV-2 strain Slovakia/SK-BMC-BA46/2023- Omicron VOC BQ.1.1.10 21K/Omicron (B.1.1.529)
005V-05468 SARS-CoV-2, 2023, Slovenia, 21K/Omicron (lineage FL.1.5.1) 21K/Omicron (B.1.1.529)
017V-05461 SARS-CoV-2 isolate - hCoV-19/France/NOR-IPP21033/2023, lineage DV.7.1
017V-05460 SARS-CoV-2 isolate - hCoV-19/France/NOR-IPP20774/2023, lineage JN.1.1
001V-05459 SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2023/FR/CCO, XBB.1.16.11 21K/Omicron (B.1.1.529)
001V-05458 SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2023/FR/GGR, EG.5.1 21K/Omicron (B.1.1.529)
005V-05430 SARS-CoV-2, 2023, Slovenia, 21K/Omicron (lineage EG.5.1) 21K/Omicron (B.1.1.529)
017V-05412 SARS-CoV-2 isolate - hCoV-19/France/IDF-IPP17625/2023, lineage BA.2.86.1 / now updated to JN.5
017V-05411 Human SARS-CoV-2 hCoV-19/France/IDF-IPP16753/2023, lineage FL.1.5.1
024V-05410 SARS-CoV-2, Human, 2020, South Africa, 501Y.V2.HV001 20H/501Y.V2/Beta, V2 (B.1.351)
024V-05409 SARS-CoV-2, Human, 2020, South Africa, 501Y.V2.HVdF002 20H/501Y.V2/Beta, V2 (B.1.351)
025V-05381 Human SARS-CoV-2 hCoV-19/Italy/VEN-IZSVe23VIR1296-12-P2_2-23/2023, lineage BQ.1.1
025V-05380 Human SARS-CoV-2 hCoV-19/Italy/VEN-IZSVe-23VIR1296-13-P2_2-23/2023, lineage CH.1.1
025V-05379 Human SARS-CoV-2 hCoV-19/Italy/VEN-IZSVe-23VIR3464-17-P2_2-23/2023, lineage XBB.1.5
017V-05364 SARS-CoV-2 isolate - hCoV-19/France/BRE-IPP15906/2023, lineage EG.5.1.3
017V-05363 SARS-CoV-2 isolate - hCoV-19/France/GES-IPP15954/2023, lineage EG.5.1.1
005V-05279 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (lineage XBB.1.16.1.1) 21K/Omicron (B.1.1.529)
009V-05261 SARS-COV-2, HUMAN, 2022, GERMANY (LINEAGE BA.5, OMICRON)
025V-05260 Human SARS-CoV-2 hCoV-19/Italy/VEN-IZSVe-21RS3504-3-P2_2-22/2022, Omicron, lineage BA.1 21K/Omicron (B.1.1.529)
025V-05259 Human SARS-CoV-2 hCoV-19/Italy/VEN-IZSVe-22RS598-3-P2_2-22/2022, Omicron, lineage BA.2
009V-05258 SARS-COV-2, HUMAN, 2021, GERMANY (LINEAGE B.1.1.318)
009V-05257 SARS-COV-2, HUMAN, 2021, GERMANY (LINEAGE B.1.621, Mu)
009V-05256 SARS-COV-2, HUMAN, 2021, GERMANY (LINEAGE B.1.617.1, Kappa)
009V-05246 SARS-COV-2, HUMAN, 2021, GERMANY (LINEAGE B.1.351, Beta)
009V-05245 SARS-COV-2, HUMAN, 2021, GERMANY (LINEAGE B.1.1.7, Alpha)
009V-05244 SARS-COV-2, HUMAN, 2020, GERMANY (LINEAGE B.1)
017V-05211 Human SARS-CoV-2, hCoV-19/France/GES-IPP07712/2023, Omicron, lineage XBB.1.16.1
001V-05046 SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2023/FR/ADP, XBB.1.9.1 21K/Omicron (B.1.1.529)
025V-05006 Human SARS-CoV-2 hCoV-19/Italy/VEN-IZSVe-22RS8210-9-P2_2-22/2022, Omicron, lineage BA.5
005V-04998 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (lineage XBB.1.5) 21K/Omicron (B.1.1.529)
005V-04997 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (lineage XBB.1.5) 21K/Omicron (B.1.1.529)
005V-04994 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (lineage XBB.1.5) 21K/Omicron (B.1.1.529)
001V-04978 SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2022/FR/4933, BF.7 21K/Omicron (B.1.1.529)
001V-04977 SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2022/FR/ACO, XBB.2 21K/Omicron (B.1.1.529)
001V-04976 SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2022/FR/LPE, BQ.1.1 21K/Omicron (B.1.1.529)
017V-04975 Human SARS-CoV-2 hCoV-19/France/PDL-IPP58867/2022, Omicron, lineage XBB.1.5
017V-04974 Human SARS-CoV-2 hCoV-19/France/HDF-IPP53307/2022, Omicron, lineage XBB.3
017V-04973 Human SARS-CoV-2 hCoV-19/France/PDL-IPP55368/2022, Omicron, lineage XBB.1
017V-04972 Human SARS-CoV-2 hCoV-19/France/NAQ-IPP58166/2022, Omicron, lineage CH.1.1.3
017V-04971 Human SARS-CoV-2 hCoV-19/France/IDF-IPP50823/2022, Omicron, lineage BQ.1.1
017V-04970 Human SARS-CoV-2 hCoV-19/France/CVL-IPP51442/2022 , Omicron, lineage BF.7
017V-04969 Human SARS-CoV-2 hCoV-19/France/IDF-IPP50347/2022, Omicron 22D, lineage BA.2.75.2
017V-04968 Human SARS-CoV-2 hCoV-19/France/HDF-IPP49210/2022, Omicron 22E, lineage BQ.1
017V-04967 Human SARS-CoV-2 hCoV-19/France/BRE-IPP47451/2022, Omicron, lineage BA.4.6
017V-04966 Human SARS-CoV-2 hCoV-19/France/BRE-IPP34319/2022, Omicron, lineage BA.5.1
017V-04965 Human SARS-CoV-2 hCoV-19/France/HDF-IPP34136/2022, Omicron, lineage BA.4
017V-04964 Human SARS-CoV-2 hCoV-19/France/PDL-IPP08031/2022, Omicron, lineage BA.2
005V-04944 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (lineage B.1.1.529.5.2.1.7, BF.7) - inactivated virus 21K/Omicron (B.1.1.529)
005V-04943 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (lineage B.1.1.529.5.3.1.1.1.1.1; BQ.1) - inactivated virus 21K/Omicron (B.1.1.529)
005V-04942 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (recombinant lineage XBB) - inactivated virus 21K/Omicron (B.1.1.529)
005V-04941 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (B.1.1.529.5.3.1.1.1.1.1.1, BQ.1.1) - inactivated virus 21K/Omicron (B.1.1.529)
005V-04939 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (lineage B.1.1.529.5.2.1.7, BF.7) 21K/Omicron (B.1.1.529)
005V-04938 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (lineage B.1.1.529.5.3.1.1.1.1.1; BQ.1) 21K/Omicron (B.1.1.529)
005V-04937 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (recombinant lineage XBB) 21K/Omicron (B.1.1.529)
017V-04908 Recombinant Delta SARS-CoV-2-nLuc-P2A-ORF7a 21A/Delta (B.1.617.2)
017V-04907 Recombinant Delta SARS-CoV-2-nLuc-P2A-ORF7a 21A/Delta (B.1.617.2)
017V-04906 Recombinant SARS-CoV-2-nLuc-P2A-ORF7a
005V-04872 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (B.1.1.529.5.3.1.1.1.1.1.1, BQ.1.1) 21K/Omicron (B.1.1.529)
007V-04772 SARS-CoV-2, Omicron BA.1, 2022
005V-04770 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (B.1.1.529.5.2.1, BA.5.2.1) 21K/Omicron (B.1.1.529)
005V-04768 SARS-CoV-2, Human, 2022, Slovenia, 21K/Omicron (B.1.1.529.2.75, BA.2.75) 21K/Omicron (B.1.1.529)
005V-04760 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (B.1.1.529.5, BA.5) - inactivated virus 21K/Omicron (B.1.1.529)
005V-04759 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (B.1.1.529.4; BA.4) - inactivated virus 21K/Omicron (B.1.1.529)
005V-04755 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (B.1.1.529.2.12.1; BA.2.12.1) 21K/Omicron (B.1.1.529)
006V-04753 SARS-CoV-2 strain Slovakia/SK-BMC-BA43/2022- Omicron VOC BE.1.1 (alias BA.5.3.1.1.1.) 21K/Omicron (B.1.1.529)
006V-04752 SARS-CoV-2 strain Slovakia/SK-BMC-BA42/2022- Omicron VOC BA.5.2 21K/Omicron (B.1.1.529)
006V-04751 SARS-CoV-2 strain Slovakia/SK-BMC-BA40/2022- Omicron VOC BA.2.9 21K/Omicron (B.1.1.529)
006V-04750 SARS-CoV-2 strain Slovakia/SK-BMC-BA39/2022- Omicron VOC BA.2.38 21K/Omicron (B.1.1.529)
006V-04749 SARS-CoV-2 strain Slovakia/SK-BMC-BA36/2022- Omicron VOC BA.2.25 21K/Omicron (B.1.1.529)
006V-04748 SARS-CoV-2 strain Slovakia/SK-BMC-BA38/2022- Omicron VOC BA.2 21K/Omicron (B.1.1.529)
006V-04747 SARS-CoV-2 strain Slovakia/SK-BMC-BA34/2022- Omicron VOC BA.1.17.2 21K/Omicron (B.1.1.529)
001V-04746 SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2022/FR/GPO, Omicron BA.5 21K/Omicron (B.1.1.529)
005V-04734 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (B.1.1.529.4; BA.4) 21K/Omicron (B.1.1.529)
005V-04726 SARS-CoV-2, 2022, Slovenia, 21K/Omicron (B.1.1.529.5, BA.5) 21K/Omicron (B.1.1.529)
010V-04723 SARS-CoV-2 omicron BA.5, Human, 2022, Netherlands
001V-04663 SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2022/FR/TCO, Omicron BA.2 21K/Omicron (B.1.1.529)
005V-04662 SARS-CoV-2, Human, 2022, Slovenia, 21K/Omicron (B.1.1.529, BA.2) 21K/Omicron (B.1.1.529)
001V-04653 SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2021/FR/1514, Omicron 21K/Omicron (B.1.1.529)
009V-04651 SARS-CoV-2, Human, 2022, Germany (Lineage B.1.1.529, Omicron variant BA.2) 21K/Omicron (B.1.1.529)
014V-04483 SARS-CoV-2, strain hCoV-19/Netherlands/NH-RIVM-27142/2021, Delta variant, lineage B.1.617.2, INACTIVATED 21A/Delta (B.1.617.2)
005V-04479 SARS-CoV-2, Human, 2021, Slovenia, 21K/Omicron (B.1.1.529) 21K/Omicron (B.1.1.529)
014V-04473 SARS-CoV-2, strain hCOV-19/Curacao/CW-RIVM-35049/2021 , Mu variant, lineage B.1.621 21H/Mu (B.1.621)
001V-04469 SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2021/FR/X1 (Lineage B 1.617.2, Delta) 21A/Delta (B.1.617.2)
017V-04441 Human SARS-CoV-2 hCoV-19/France/PDL-IPP46934/2021, Omicron, lineage BA.1 21K/Omicron (B.1.1.529)
009V-04437 SARS-CoV-2, human, 2021, Germany (Lineage B.1.1.529, Omicron variant BA.1) 21K/Omicron (B.1.1.529)
001V-04436 SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2021/CO/6600 (Mu) 21H/Mu (B.1.621)
014V-04430 SARS-CoV-2, strain hCoV-19/Netherlands/NH-RIVM-71076/2021, Omicron variant, lineage B.1.1.529 21K/Omicron (B.1.1.529)
014V-04429 SARS-CoV-2, strain hCoV-19/Netherlands/NH-RIVM-72291/2021, Omicron variant, lineage B.1.1.529 21K/Omicron (B.1.1.529)
010V-04425 SARS-CoV-2, strain hCoV-19/Netherlands/NH-EMC-1720/2021, Omicron variant, lineage B.1.1.529 - Calu 3 culture 21K/Omicron (B.1.1.529)
005V-04420 SARS-CoV-2, strain hCoV-19/Slovenia/410212/21 (lineage AY.4.2) 21A/Delta (B.1.617.2)
008V-04418 SARS-CoV-2 virus, strain hCoV-19/Italy/LAZ-INMI-642isl/2021 (clade GK, lineage B.1.617, B.1.617.1-like)
008V-04417 SARS-CoV-2 virus, former VOC Beta GH/501Y.V2 (B.1.351+B.1.351.2+B.1.351.3) first detected in South Africa, strain hCoV-19/Italy/LAZ-INMI-494isl/2021 (clade GH, lineage B.1.351.3, Beta (B.1.351-like)) 20H/501Y.V2/Beta, V2 (B.1.351)
005V-04401 SARS-CoV-2, strain hCoV-19/Slovenia/296835/21 (lineage B.1.526) 20C/484K or 20C/477N (B.1.526)
017V-04400 Human 2019-nCoV - hCoV-19/France/HDF-IPP11602i/2021, clade 21A/B.1.617.2 21A/Delta (B.1.617.2)
005V-04398 SARS-CoV-2, strain hCoV-19/Slovenia/60296/21 (lineage C.16) C.16 (B.1.1.1.16)
005V-04397 SARS-CoV-2, strain hCoV-19/Slovenia/308315/21 (lineage C.36.3) C.36.3 (B.1.1.1.36.3)
005V-04396 SARS-CoV-2, strain hCoV-19/Slovenia/188058/21 (lineage B.1.617.1) 21B/Kappa (B.1.617.1)
005V-04395 SARS-CoV-2, strain hCoV-19/Slovenia/292525/21 (lineage B.1.1.318) 20B/681H (B.1.1.318)
005V-04394 SARS-CoV-2, strain hCoV-19/Slovenia/20021/21 (lineage B.1.258.17)
006V-04329 SARS-CoV-2 strain Slovakia/SK-BMC-BA15/2021- B.1.617.2 variant (a.k.a. Delta VOC or "Indian variant") 21A/Delta (B.1.617.2)
001V-04282 SARS-CoV-2 virus, strain SARS-CoV-2/2021/FR/0610 (Lineage B 1.617.2, Delta) 21A/Delta (B.1.617.2)
014V-04279 SARS-CoV-2, strain hCoV-19/Netherlands/NH-RIVM-27142/2021, Delta variant, lineage B.1.617.2 21A/Delta (B.1.617.2)
014V-04278 SARS-CoV-2, strain hCoV-19/Netherlands/UT-RIVM-15598/2021, Eta variant, lineage B.1.525 20A/484K (B.1.525)
014V-04277 SARS-CoV-2, strain hCoV-19/St-Maarten/SX-RIVM-13806/2021, Iota variant, lineage B.1.526 20C/484K or 20C/477N (B.1.526)
014V-04276 SARS-CoV-2, strain hCoV-19/Netherlands/UT-RIVM-12844/2021, Alpha variant + E484K, nextstrain clade 20I/501Y.V1, lineage B.1.1.7 20I/484K or 484Q (B.1.1.7 + E484K/Q)
004V-04252 Human nCoV19 isolate/UK ex-India/HCM/V/078 SARS-CoV-2 (Lineage B.1.617.2) 21A/Delta (B.1.617.2)
005V-04249 SARS-CoV-2, Human, 2021, Slovenia ex India, 21A/478K.V1 (B.1.617.2, Delta) 21A/Delta (B.1.617.2)
005V-04248 SARS-CoV-2, Human, 2021, Slovenia ex imported, 20J/501Y.V3 (P.1) 20J/501Y.V3/Gamma, V3 (P.1)
017V-04219 SARS-CoV-2 isolate - hCoV-19/France/BRE-IPP04392/2021, clade 20C, lineage B.1.616 20C/655Y (B.1.616)
017V-04212 Human SARS-CoV-2 - hCoV-19/French Guiana/IPP03772/2021, lineage P.1 20J/501Y.V3/Gamma, V3 (P.1)
017V-04211 SARS-CoV-2 isolate - BetaCoV/Mayotte/IPP00884/2021, lineage A.27
012V-04195 SARS-CoV-2, hCoV-19/Sweden/21-51217/2021 (lineage B.1.351, ex South African variant) 20H/501Y.V2/Beta, V2 (B.1.351)
012V-04194 SARS-CoV-2, hCoV-19/Sweden/20-53840/2020 (lineage B 1. 1 .7, UK) 20I/501Y.V1/Alpha, V1 (B.1.1.7)
012V-04193 SARS-CoV-2, hCoV-19/Sweden/20-53787/2020 (lineage B 1. 1 .7, UK) 20I/501Y.V1/Alpha, V1 (B.1.1.7)
001V-04191 SARS-CoV-2 virus, strain SARS-CoV-2/2021/FR/4700 (lineage A27-like)
001V-04190 SARS-CoV-2 virus, strain SARS-CoV-2/2021/JP/TY7-503 (lineage P.1, ex Brazil) 20J/501Y.V3/Gamma, V3 (P.1)
001V-04189 SARS-CoV-2 virus, strain SARS-CoV-2/2021/JP/TY7-501 (lineage P.1, ex Brazil) 20J/501Y.V3/Gamma, V3 (P.1)
009V-04187 SARS-CoV-2, Human, 2021, Germany ex India, 20A/452R (B.1.617) 20A/452R (B.1.617)
008V-04186 SARS-CoV-2 virus, former VOI Eta G/484K.V3 (B.1.525) first detected in UK/Nigeria, strain hCoV-19/Italy/LAZ-INMI-289isl/2021, Q52R, Δ69-70, Δ144, E484K, Q677H, F888L (S) (clade G, lineage B.1.525, Eta (B.1.525-like)) 20A/484K (B.1.525)
008V-04185 SARS-CoV-2 virus, former VOC Alpha GRY (B.1.1.7+Q.*) first detected in the UK, strain hCoV-19/Italy/LAZ-INMI-129isl/2020, Δ69-70, Δ144, N501Y, A570D, D614G, P681H, T716I (S) (clade GRY, lineage B.1.1.7, Alpha (B.1.1.7-like)) 20I/501Y.V1/Alpha, V1 (B.1.1.7)
006V-04183 SARS-CoV-2 strain Slovakia/SK-BMC-BA11/2021- B.1.351 variant (a.k.a. 20H/501Y.V2 or "South African variant") 20H/501Y.V2/Beta, V2 (B.1.351)
005V-04144 SARS-CoV-2, strain hCoV-19/Slovenia/65006/21 (A.27) (D796Y, G1219V, A653V, H655Y, N501Y) 19B/501Y (A.27)
005V-04110 SARS-CoV-2, strain hCoV-19/Slovenia/65882/21 (lineage A.27) (D796Y, G1219V, A653V, H655Y, N501Y) 19B/501Y (A.27)
005V-04109 SARS-CoV-2, strain hCoV-19/Slovenia/57573/21 (lineage B.1.525) 20A/484K (B.1.525)
005V-04107 SARS-CoV-2, strain hCoV-19/Slovenia/71693/21 (lineage B.1.351) 20H/501Y.V2/Beta, V2 (B.1.351)
008V-04101 SARS-CoV-2 virus, former VOC Gamma GR/501Y.V3 (P.1+P.1.*) first detected in Brazil/Japan, strain hCoV-19/Italy/LAZ-INMI-216isl/2021, K417T, E484K, N501Y (S) (clade GR, lineage P.1, Gamma (P.1-like)) 20J/501Y.V3/Gamma, V3 (P.1)
014V-04092 SARS-CoV-2 virus, strain hCoV-19/Netherlands/Gelderland_20949/2021, N501T (S), nextstrain clade 20D, lineage C.2
014V-04091 SARS-CoV-2 virus, strain hCoV-19/Aruba_11401/2021, California variant, nextstrain clade CAL.20C, lineage B.1.429 20C/452R (B.1.427/ B.1.429)
014V-04090 SARS-CoV-2 virus, strain hCoV-19/Netherlands/NoordBrabant_10706/2021, Brazilian variant P.2, nextstrain clade 20B, lineage B.1.1.28 P.2 20B/484K.V1 (P.2)
014V-04089 SARS-CoV-2 virus, strain hCoV-19/Netherlands/NoordHolland_10915/2021, Brazilian variant P.1, nextstrain clade 20J, lineage B.1.1.28 P.1 20J/501Y.V3/Gamma, V3 (P.1)
017V-04087 Human 2019-nCoV - hCoV-19/France/PDL-IPP01065/2021, clade 20H/501Y.V2 20H/501Y.V2/Beta, V2 (B.1.351)
006V-04083 SARS-CoV-2 strain Slovakia/SK-BMC-P1A/2021- B.1.1.7 variant (VOC 202012/01) 20I/501Y.V1/Alpha, V1 (B.1.1.7)
001V-04080 SARS-CoV-2 virus, isolate England/MIG457/2020 (lineage B.1.1.7) 20I/501Y.V1/Alpha, V1 (B.1.1.7)
004V-04071 Human nCoV19 isolate/England ex-SA/HCM002/2021 (lineage B.1.351) 20H/501Y.V2/Beta, V2 (B.1.351)
001V-04067 SARS-CoV-2, UVE/SARS-CoV-2/2021/FR/1299-ex SA (lineage B 1.351) 20H/501Y.V2/Beta, V2 (B.1.351)
014V-04058 SARS-CoV-2 virus, strain hCoV-19/Netherlands/NoordHolland_10159/2021, South African variant, nextstrain clade 20H, lineage B.1.351 20H/501Y.V2/Beta, V2 (B.1.351)
017V-04055 Human 2019-nCoV - hCoV-19/France/IDF-IPP11324/2020, clade 20I/501Y.V1 20I/501Y.V1/Alpha, V1 (B.1.1.7)
005V-04053 SARS-CoV-2, strain hCoV-19/Slovenia/11454/21 (lineage B 1.1.7, exUK) 20I/501Y.V1/Alpha, V1 (B.1.1.7)
012V-04052 SARS-CoV-2, hCoV-19/Sweden/20-53846/2020 (lineage B 1. 1 .7, UK) 20I/501Y.V1/Alpha, V1 (B.1.1.7)
008V-04050 SARS-CoV-2 virus, former VOC Alpha GRY (B.1.1.7+Q.*) first detected in the UK, strain hCoV-19/Italy/CAM-INMI-118isl/2020, Δ69-70, Δ144, N501Y, A570D, D614G, P681H, T716I (S), (clade GRY, lineage B.1.1.7 , Alpha (B.1.1.7-like)) 20I/501Y.V1/Alpha, V1 (B.1.1.7)
008V-04049 SARS-CoV-2 virus, strain hCoV-19/Italy/LAZ-INMI-115isl/2020, D69-70, D614G (S) (clade G, lineage B.1.258.7)
008V-04048 SARS-CoV-2 virus, strain hCoV-19/Italy/LAZ-INMI-82isl/2020, A222V, D614G (S) (clade GV, lineage B.1.177)
008V-04047 SARS-CoV-2 virus, strain hCoV-19/Italy/LAZ-INMI-24/2020, D614G (S) (clade GH, lineage B.1.389)
001V-04044 SARS-CoV-2, UVE/SARS-CoV-2/2021/FR/7b (lineage B 1. 1 .7, ex UK) 20I/501Y.V1/Alpha, V1 (B.1.1.7)
004V-04032 Human nCoV19 isolate/England/MIG457/2020 (lineage B.1.1.7) 20I/501Y.V1/Alpha, V1 (B.1.1.7)
014V-04031 SARS-CoV-2 virus, strain hCoV-19/Netherlands/NoordHolland_20432/2020, VOC 202012/01, nextstrain clade 20I/501Y.V1, lineage B.1.1.7 20I/501Y.V1/Alpha, V1 (B.1.1.7)
014V-04030 SARS-CoV-2 virus, strain hCoV-19/Netherlands/NoordHolland_10006/2020, Netherlands ex Iran
001V-04006 SARS-CoV-2 virus, strain UVE/SARS-CoV2/2020/FR/ISA_D614
008V-04005 SARS-CoV-2 virus, hCoV-19/Italy/LOM-INMI-10734/2020, D614G (S) (clade G, lineage B.1)
008V-03992 SARS-CoV-2 virus, strain hCoV-19/Italy/LAZ-INMI4/2020, D614G (S), G204R (N) (clade GR, lineage B.1.1)
002V-03991 SARS-CoV-2 human/DEU/HH-1/2020
014V-03981 SARS-CoV-2 virus, hCoV-19/Netherlands/NoordBrabant_10003/2020, clade B, D614 (S)
006V-03971 SARS-CoV-2 strain Slovakia/SK-BMC6/2020
014V-03968 SARS-CoV-2 virus, strain hCoV-19/Netherlands/ZuidHolland_10004/2020, clade B1.1, D614G (S)
001V-03967 SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2020/FR/702
005V-03961 SARS-CoV-2 strain Slovenia/SI-4265/20, D614G
017V-03960 Human 2019-nCoV - hCoV-19/France/GE1973/2020, clade G, D614G (S)
006V-03937 SARS-CoV-2 strain Slovakia/SK-BMC5/2020 FD
006V-03933 SARS-CoV-2 strain Slovakia/SK-BMC5/2020
010V-03903 SARS-CoV-2 strain /NL/2020
008V-03893 SARS-CoV-2 virus, strain hCoV-19/Italy/LAZ-INMI1-isl/2020 (clade O, lineage B)
014V-03890 SARS-CoV-2 isolate - BetaCoV/France/IDF0372/2020
026V-03883 Human 2019-nCoV Isolate
Service Products
REF/SKU Variant
001S-04431 SARS-CoV-2 in vitro infection
003S-03900 SARS-CoV-2 diagnostic training
026S-03464 Rapid reverse genetic as ISA on SARS-COV
006S-03089 Access to the UNIBAS BSL-3 infrastructure with theoretical and practical introduction and hands-on project training. Includes training in biosafety and safe work with RG3 viral pathogens
014S-03059 Institut Pasteur Paris - Management of biosafety and biosecurity in BSL3 containment facilities. The access will comprise a detailed theoretical and, subject to availability, practical application of the biosafety and biosecurity management of BSL3 in Ins
001S-02899 Training course: Next Generation Sequencing training for Ion torrent S5 sequencing
001S-02696 Training course: Lyophilization as a convenient method for long-term preservation of virus strains and derived products such as inactivated quality controls
003S-02038 Access to virus whole genome sequencing service at APHA
007S-01703 Access to UL infrastructure
009S-01682 Access to the INMI BSL-3 infrastructures for theoretical and practical training on biosafety and techniques related to RG3 virus isolation
002S-01572 Access to BSL-4 laboratory
001S-EVA363 Strain isolation from clinical sample
Protein Products
REF/SKU Variant
022P-05178 SARS-Cov-2 E-protein peptide antigens
022P-05177 SARS-CoV-2 orf6 peptide antigens
014P-05045 SARS-CoV-2 BA.4/BA.5 (B.1.1.529.4/5) Spike recombinant protein 21K/Omicron (B.1.1.529)
014P-05044 SARS-CoV-2 A.30 Spike recombinant protein
014P-05043 SARS-CoV-2 BA.2.75 (B.1.1.529.2.75) Spike recombinant protein 21K/Omicron (B.1.1.529)
014P-05042 SARS-CoV-2 BA.3 (B.1.1.529.3) Spike recombinant protein 21K/Omicron (B.1.1.529)
014P-05041 SARS-CoV-2 BA.2 (B.1.1.529.2) Spike recombinant protein 21K/Omicron (B.1.1.529)
014P-05040 SARS-CoV-2 BA.1 (B.1.1.529.1) Spike recombinant protein 21K/Omicron (B.1.1.529)
014P-05039 SARS-CoV-2 C.1.2 Spike recombinant protein
014P-05038 SARS-CoV-2 B.1.640 Spike recombinant protein
014P-05037 SARS-CoV-2 B.1.427 Spike recombinant protein 20C/452R (B.1.427/ B.1.429)
014P-05036 SARS-CoV-2 B.1.621 Spike recombinant protein 21H/Mu (B.1.621)
014P-05035 SARS-CoV-2 C.37 Spike recombinant protein 20D/Lambda (C.37)
014P-05034 SARS-CoV-2 B.1.525 Spike recombinant protein 21D/Eta (B.1.525)
014P-05033 SARS-CoV-2 P.3 Spike recombinant protein 20B/501Y (P.3)
014P-05032 SARS-CoV-2 P.2 Spike recombinant protein 20B/484K.V1 (P.2)
014P-05031 SARS-CoV-2 B.1.526 Spike recombinant protein 21F/Iota (B.1.526)
014P-05030 SARS-CoV-2 B.1.617.1 Spike recombinant protein 21B/Kappa (B.1.617.1)
014P-05029 SARS-CoV-2 B.1.617.2 Spike recombinant protein 21A/Delta (B.1.617.2)
014P-05028 SARS-CoV-2 P.1 Spike recombinant protein 20J/501Y.V3/Gamma, V3 (P.1)
014P-05027 SARS-CoV-2 B.1.351 Spike recombinant protein 20H/501Y.V2/Beta, V2 (B.1.351)
014P-05026 SARS-CoV-2 B.1.1.7 Spike recombinant protein 20I/501Y.V1/Alpha, V1 (B.1.1.7)
014P-05025 SARS-CoV-2 Spike recombinant protein
022P-04984 SARS-CoV-2 RBD-SD1 variant XBB1.5
022P-04982 SARS-CoV-2 RBD-SD1 variant BA.5
022P-04909 SARS-CoV-2 recombinant Nsp1protein
024P-04762 SARS-CoV-2 nucleocapsid phosphoprotein (N) protein, Full length
022P-04480 SARS-CoV-2 recombinant RBD-SD1 Omicron variant 21K/Omicron (B.1.1.529)
022P-04415 SARS-CoV-1 recombinant RBD-SD1
022P-04363 SARS-Cov-2 recombinant RBD-SD1 Delta variant
022P-04339 SARS-CoV-2 recombinant RBD variant E484K-N501Y
022P-04338 SARS-CoV-2 recombinant RBD variant L452R-N501Y
022P-04337 SARS-CoV-2 recombinant RBD variant E484K
022P-04336 SARS-CoV-2 recombinant RBD variant E484Q
022P-04335 SARS-CoV-2 recombinant RBD variant S477N
022P-04334 SARS-CoV-2 recombinant RBD variant T478K
022P-04333 SARS-CoV-2 recombinant RBD variant L452R
022P-04332 SARS-CoV-2 recombinant RBD variant L452R-E484Q
022P-04308 SARS-CoV-2 recombinant RBD-SD1 Gamma variant
022P-04307 SARS-CoV-2 recombinant RBD-SD1 Beta variant
022P-04306 SARS-CoV-2 recombinant RBD-SD1 Alpha variant
022P-04134 SARS-Cov-2 recombinant S1 domain
022P-04124 SARS-CoV-2 recombinant N-terminal domain
022P-03958 SARS-CoV-2 recombinant RBD-SD1
100P-03957 CTD of the SARS-CoV-2 nucleoprotein
100P-03956 NTD of the SARS-CoV-2 nucleoprotein
022P-03940 recombinant receptor-binding domain (RBD) of SARS-CoV-2 HisTag
Nucleic Acid Products
REF/SKU Variant
009N-05277 SARS-COV-2 RNA, HUMAN, 2022, GERMANY (LINEAGE BA.5, OMICRON)
009N-05276 SARS-COV-2 RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.621, Mu)
009N-05275 SARS-COV-2 RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.1.318)
009N-05274 SARS-COV-2 RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.617.1, Kappa)
009N-05273 SARS-COV-2 RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.351, Beta)
009N-05272 SARS-COV-2 RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.1.7, Alpha)
009N-05271 SARS-COV-2 RNA, HUMAN, 2020, GERMANY (LINEAGE B.1)
005N-04948 SARS-CoV-2 RNA, 21K/Omicron, strain hCoV-19/Slovenia/LP3/3/23 (lineage B.1.1.529.5.2.1.7, BF.7) 21K/Omicron (B.1.1.529)
005N-04947 SARS-CoV-2 RNA, 21K/Omicron, strain hCoV-19/Slovenia/LP3/2/23 (lineage B.1.1.529.5.3.1.1.1.1.1; BQ.1) 21K/Omicron (B.1.1.529)
005N-04946 SARS-CoV-2 RNA, 21K/Omicron, strain hCoV-19/Slovenia/LP3/1/23 (recombinant lineage XBB) 21K/Omicron (B.1.1.529)
005N-04945 SARS-CoV-2 RNA, 21K/Omicron, strain hCoV-19/Slovenia/232863/22 (lineage BQ.1.1) 21K/Omicron (B.1.1.529)
010N-04427 SARS-CoV-2, strain hCoV-19/Netherlands/NH-EMC-1720/2021, Omicron variant, lineage B.1.1.529 – RNA 21K/Omicron (B.1.1.529)
009N-04244 RNA SARS-CoV-2 strain B.1.617 (Germany ex India) 20A/452R (B.1.617)
001N-04192 RNA of UVE/SARS-CoV-2/2021/FR/1299-ex SA 20H/501Y.V2/Beta, V2 (B.1.351)
014N-04150 SARS-CoV-2 RNA, strain hCoV-19/Netherlands/NoordHolland_10915/2021, Brazilian variant P.1, nextstrain clade 20J, lineage B.1.1.28 P.1
014N-04149 SARS-CoV-2 RNA, strain hCoV-19/Netherlands/NoordBrabant_10706/2021, Brazilian variant P.2, nextstrain clade 20B, lineage B.1.1.28 P.2
014N-04148 SARS-CoV-2 RNA, strain hCoV-19/Netherlands/Gelderland_20949/2021, N501T (S), nextstrain clade 20D, lineage C.2
014N-04147 SARS-CoV-2 RNA, strain hCoV-19/Netherlands/NoordHolland_10159/2021, South African variant, nextstrain clade 20H, lineage B.1.351 20H/501Y.V2/Beta, V2 (B.1.351)
014N-04146 SARS-CoV-2 RNA, strain hCoV-19/Aruba_11401/2021, California variant, nextstrain clade CAL.20C, lineage B.1.429 20C/452R (B.1.427/ B.1.429)
005N-04125 SARS-CoV-2 RNA, strain hCoV-19/Slovenia/57573/21 (lineage B.1.525) 20A/484K (B.1.525)
005N-04108 SARS-CoV-2 RNA, strain hCoV-19/Slovenia/71693/21 (lineage B.1.351) 20H/501Y.V2/Beta, V2 (B.1.351)
005N-04054 SARS-CoV-2 RNA, strain hCoV-19/Slovenia/11454/21 (lineage B 1.1.7, exUK) 20I/501Y.V1/Alpha, V1 (B.1.1.7)
001N-04051 RNA of SARS-CoV-2/2021/FR/7b (lineage B 1. 1 .7, ex UK) 20I/501Y.V1/Alpha, V1 (B.1.1.7)
006N-03939 SARS-CoV-2 strain Slovakia/SK-BMC5/2020, cDNA
006N-03938 SARS-CoV-2 strain Slovakia/SK-BMC5/2020, RNA
003N-03901 Wuhan coronavirus 2019 RdRP gene control
008N-03894 Human 2019-nCoV strain 2019-nCoV/Italy-INMI1 RNA
026N-03889 Human 2019-nCoV RNA
011N-03868 Coronavirus RNA specificity panel
026N-03866 Wuhan coronavirus 2019 E gene control
004N-02005 SARS-CoV Frankfurt 1 RNA
004N-EVA1386 MERS-CoV (hCoV-EMC) upstream E (upE) assay (screening assay)
004N-EVA1407 MERS-CoV (hCoV-EMC) 1A assay (confirmatory assay)
004N-EVA254 SARS-CoVFrankfurt 1 Isolate (IVT RNA)
Detection Kit Products
REF/SKU Variant
002K-04650 SARS-CoV-2 IgG High Sensitivity ELISA Kit
002K-04648 SARS-CoV-2 IgG ELISA Kit
001K-04413 Encapsidated RNA corresponding to the 5' region on the Spike coding sequence from SARS-CoV-2 alpha variant 20I/501Y.V1/Alpha, V1 (B.1.1.7)
001K-04412 Encapsidated RNA corresponding to the 5' region on the Spike coding sequence from SARS-CoV-2 beta variant 20H/501Y.V2/Beta, V2 (B.1.351)
001K-04411 Encapsidated RNA corresponding to the 5' region on the Spike coding sequence from SARS-CoV-2 BavPat1 strain (D614G)
001K-04410 Encapsidated RNA corresponding to the 5' region on the Spike coding sequence from SARS-CoV-2 from SARS-CoV-2 delta variant 20A/452R (B.1.617)
001K-04409 Encapsidated RNA corresponding to the 5' region on the Spike coding sequence from SARS-CoV-2 gamma variant 20J/501Y.V3/Gamma, V3 (P.1)
001K-03964 Lyophilized Primers and Probe for RT-PCR in the SARS-CoV-2 N (CUB) gene
001K-03954 SARS-CoV-2 N (CUB) gene stabilized RNA as positive control: shipping at Room Temperature
001K-03952 Lyophilized Primers and Probe for RT-PCR in the SARS-CoV-2 RdRp (IP4) gene
001K-03934 SARS-CoV-2 RdRp (IP2/IP4) gene stabilized RNA as positive control: shipping at Room Temperature
012K-03928 SARS-CoV-2 (2019-nCoV) IF-slides
001K-03906 Lyophilized Primers and Probe for RT-PCR in the SARS-CoV-2 RdRp gene
001K-03905 SARS-CoV-2 RdRp gene stabilized RNA as positive control: shipping at Room Temperature
001K-03885 Lyophilized Primers and Probe for RT-PCR in the 2019-nCoV E gene
001K-03884 2019-nCoV E gene stabilized RNA as positive control: shipping at Room Temperature
Bundle Products
REF/SKU Variant
001B-04287 Panel of SARS-CoV-2 variants 20I/501Y.V1/Alpha, V1 (B.1.1.7), 20H/501Y.V2/Beta, V2 (B.1.351), 20A/452R (B.1.617), 20J/501Y.V3/Gamma, V3 (P.1)
001B-03965 Primers, Probe and encapsidated RNA pos. control - SARS-CoV-2 N (CUB) gene, small packaging
001B-03955 Primers, Probe and encapsidated RNA pos. control - SARS-CoV-2 RdRp (IP4) gene, small packaging
001B-03929 Primers, Probe and encapsidated RNA pos. control - SARS-CoV-2 RdRp gene, medium packaging
001B-03907 Primers, Probe and encapsidated RNA pos. control - SARS-CoV-2 RdRp gene, small packaging
001B-03888 Primers, Probe and encapsidated RNA pos. control - 2019-nCoV E gene, Large packaging
001B-03887 Primers, Probe and encapsidated RNA pos. control - 2019-nCoV E gene, Medium packaging
001B-03886 Primers, Probe and encapsidated RNA pos. control - 2019-nCoV E gene, small packaging
100B-03867 Diagnostics controls for Wuhan coronavirus 2019 / 2019-nCoV
Antibody or Hybridoma Products
REF/SKU Variant
010A-05022 Human anti-SARS-CoV-2 Spike protein (S2) IgG1, monoclonal antibody (clone BCP007)
010A-05021 Human anti-SARS-CoV-2 Spike protein (S1) IgG1, monoclonal antibody (clone BCP005)
010A-05020 Human anti-SARS-CoV-2 Spike protein (S1) IgG1, monoclonal antibody (clone BCP003)
010A-05019 Human anti-SARS-CoV-2 Spike protein (S2) IgG1, monoclonal antibody (clone BCP008)
010A-05017 Human anti-SARS-CoV-2 Spike protein (S2) IgG1, monoclonal antibody (clone BCP006)
010A-04961 Human anti-SARS-CoV-2 Spike protein (RBD) IgG1, monoclonal antibody (clone BCP004)
025A-04955 Anti Sars-Cov-2 virus (Parental) polyclonal sera.
025A-04864 Anti Sars-Cov-2 virus (Parental) polyclonal sera.
024A-04304 SARS-CoV-2 Nucleocapsid protein monoclonal antibody
024A-04029 SARS-CoV-2 nucleoprotein antiserum
024A-04028 SARS-CoV-2 nucleoprotein antiserum
015A-01748 murine mAb: anti-Severe acute respiratory syndrome coronavirus NP (anti-SARS NP)


HOW TO RECEIVE FREE OF CHARGE SARS-CoV-2 diagnostics controls and viral strains:
  1. Add only one SARS-CoV-2 related product at a time to your cart. Please note that for free of charge demands, only one product at a time should be ordered. If you want to request more than one product, simply place separate orders.

    If you have more than one product in your cart, you won't be able to select the "free of charge option". This procedure is necessary to allow proper evaluation of your demand by our Selection Panel, and for transparency reasons towards the European Commission who will be sponsoring financially your access.

  2. Create an account, or Log on to our portal
  3. Fill in the required billing and shipping information, intended use, and technical description. Please indicate if you need an import permit in case you ordered the SARS RNA control product.
  4. Don’t forget to tick the box for free of charge access
  5. Accept the terms and conditions* (mandatory)
  6. Complete you enquiry
Your enquiry will be forwarded to our Selection Panel that will evaluate your demand based on criteria defined in the European Commission specific provisions for transnational access activities guidelines.

This whole procedure will take less than 24h.

Once your enquiry is accepted, you will be put in contact with our EVA-GOBAL partner to arrange the shipment.

* May we bring your attention to clause 4 and 14 of EVA-GOBAL Terms and Conditions preventing redistribution of our products, and asking for citation of our organization in any publication resulting from the use of our products

LATEST RESULTS: Visit our page dedicated to antiviral compounds test results against COVID19

Comments (3)

  • Varsha Potdar's picture

    I applied online for the above mentioned positive control
    National Institute of virology pune is WHO designated national Influenza centre and worked for public helath important viruses .
    To have countries preparedness in place we required the positive control to set laboratory diagnosis

    Jan 18, 2020
  • Isabelle Thomas's picture

    We would like to order this control free of charge, fir the NIC Belgium in order to perform diagnosis of the new coronavirus

    Jan 20, 2020
  • K.Miyauchi's picture

    Thanks for these comments! Ordering these products is simple - we have described the process on this page under the title: HOW TO RECEIVE FREE OF CHARGE 2019-nCoV diagnostics controls.

    This comments section is not regularly monitored, so if you have any urgent questions about the products or the ordering process I would encourage you to contact us through our contact page that is available from the header and the footer menus of this page.

     

    Jan 23, 2020
Login